Skip to main content
PMC home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1983 Dec;47(4):510–550. doi: 10.1128/mr.47.4.510-550.1983

New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

M M Levine, J B Kaper, R E Black, M L Clements
PMCID: PMC281589  PMID: 6363898

Full text

PDF
510

Images in this article

525Image
on p.525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHCROFT M. T., RITCHIE J. M., NICHOLSON C. C. CONTROLLED FIELD TRIAL IN BRITISH GUIANA SCHOOL CHILDREN OF HEAT-KILLED-PHENOLIZED AND ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES. Am J Hyg. 1964 Mar;79:196–206. doi: 10.1093/oxfordjournals.aje.a120376. [DOI] [PubMed] [Google Scholar]
  2. ASHCROFT M. T., RITCHIE J. M., NICHOLSON C. C., STUART C. A. ANTIBODY RESPONSES TO VACCINATION OF BRITISH GUIANA SCHOOLCHILDREN WITH HEART-KILLED-PHENOLIZED AND ACETONE-KILLED LYOPHILIZED TYPHOID VACCINES. Am J Hyg. 1964 Sep;80:221–228. doi: 10.1093/oxfordjournals.aje.a120470. [DOI] [PubMed] [Google Scholar]
  3. ASHCROFT M. T. TYPHOID AND PARATYPHOID FEVERS IN THE TROPICS. J Trop Med Hyg. 1964 Aug;67:185–189. [PubMed] [Google Scholar]
  4. Acres S. D., Isaacson R. E., Babiuk L. A., Kapitany R. A. Immunization of calves against enterotoxigenic colibacillosis by vaccinating dams with purified K99 antigen and whole cell bacterins. Infect Immun. 1979 Jul;25(1):121–126. doi: 10.1128/iai.25.1.121-126.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Adamus G., Mulczyk M., Witkowska D., Romanowska E. Protection against keratoconjunctivitis shigellosa induced by immunization with outer membrane proteins of Shigella spp. Infect Immun. 1980 Nov;30(2):321–324. doi: 10.1128/iai.30.2.321-324.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ahlqvist J., Ahvonen P., Räsänen J. A., Wallgren G. R. Enteric infection with Yersinia enterocolitica. Large pyroninophilic cell reaction in mesenteric lymph nodes associated with early production of specific antibodies. Acta Pathol Microbiol Scand A. 1971;79(2):109–122. [PubMed] [Google Scholar]
  7. André C., Bazin H., Heremans J. F. Influence of repeated administration of antigen by the oral route on specific antibody-producing cells in the mouse spleen. Digestion. 1973;9(2):166–175. doi: 10.1159/000197442. [DOI] [PubMed] [Google Scholar]
  8. André C., Heremans J. F., Vaerman J. P., Cambiaso C. L. A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med. 1975 Dec 1;142(6):1509–1519. doi: 10.1084/jem.142.6.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Angerman C. R., Eisenstein T. K. Correlation of the duration and magnitude of protection against Salmonella infection afforded by various vaccines with antibody titers. Infect Immun. 1980 Feb;27(2):435–443. doi: 10.1128/iai.27.2.435-443.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ashcroft M. T., Singh B., Nicholson C. C., Ritchie J. M., Sorryan E., Williams F. A seven-year field trial of two typhoid vaccines in Guyana. Lancet. 1967 Nov 18;2(7525):1056–1059. doi: 10.1016/s0140-6736(67)90335-2. [DOI] [PubMed] [Google Scholar]
  11. Attridge S. R., Rowley D. The role of the flagellum in the adherence of Vibrio cholerae. J Infect Dis. 1983 May;147(5):864–872. doi: 10.1093/infdis/147.5.864. [DOI] [PubMed] [Google Scholar]
  12. Attridge S. R., Rowley D. The specificity of Vibrio cholerae adherence and the significance of the slime agglutinin as a second mediator of in vitro attachment. J Infect Dis. 1983 May;147(5):873–881. doi: 10.1093/infdis/147.5.873. [DOI] [PubMed] [Google Scholar]
  13. BURNET F. M. Ovomucin as a substrate for the mucinolytic enzymes of V cholerae filtrates. Aust J Exp Biol Med Sci. 1949 May;27(3):245–252. doi: 10.1038/icb.1949.25. [DOI] [PubMed] [Google Scholar]
  14. BURNET F. M. The mucinase of V. cholerae. Aust J Exp Biol Med Sci. 1948 Jan;26(Pt 1):71–80. doi: 10.1038/icb.1948.8. [DOI] [PubMed] [Google Scholar]
  15. Baine W. B., Mazzotti M., Greco D., Izzo E., Zampieri A., Angioni G., Di Gioia M., Gangarosa E. J., Pocchiari F. Epidemiology of cholera in Italy in 1973. Lancet. 1974 Dec 7;2(7893):1370–1374. doi: 10.1016/s0140-6736(74)92233-8. [DOI] [PubMed] [Google Scholar]
  16. Baldini M. M., Kaper J. B., Levine M. M., Candy D. C., Moon H. W. Plasmid-mediated adhesion in enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr. 1983;2(3):534–538. doi: 10.1097/00005176-198302030-00023. [DOI] [PubMed] [Google Scholar]
  17. Barrett-Connor E., Connor J. D. Extraintestinal manifestations of shigellosis. Am J Gastroenterol. 1970 Mar;53(3):234–245. [PubMed] [Google Scholar]
  18. Bergman M. J., Updike W. S., Wood S. J., Brown S. E., 3rd, Guerrant R. L. Attachment factors amont enterotoxigenic Escherichia coli from patients with acute diarrhea from diverse geographic areas. Infect Immun. 1981 May;32(2):881–888. doi: 10.1128/iai.32.2.881-888.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Bhattacharjee J. W., Srivastava B. S. Mannose-sensitive haemagglutinins in adherence of Vibrio cholerae eltor to intestine. J Gen Microbiol. 1978 Aug;107(2):407–410. doi: 10.1099/00221287-107-2-407. [DOI] [PubMed] [Google Scholar]
  20. Black R. E., Brown K. H., Becker S., Alim A. R., Huq I. Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol. 1982 Mar;115(3):315–324. doi: 10.1093/oxfordjournals.aje.a113308. [DOI] [PubMed] [Google Scholar]
  21. Black R. E., Merson M. H., Huq I., Alim A. R., Yunus M. Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. Lancet. 1981 Jan 17;1(8212):141–143. doi: 10.1016/s0140-6736(81)90719-4. [DOI] [PubMed] [Google Scholar]
  22. Black R. E., Merson M. H., Rowe B., Taylor P. R., Abdul Alim A. R., Gross R. J., Sack D. A. Enterotoxigenic Escherichia coli diarrhoea: acquired immunity and transmission in an endemic area. Bull World Health Organ. 1981;59(2):263–268. [PMC free article] [PubMed] [Google Scholar]
  23. Blake P. A., Allegra D. T., Snyder J. D., Barrett T. J., McFarland L., Caraway C. T., Feeley J. C., Craig J. P., Lee J. V., Puhr N. D. Cholera--a possible endemic focus in the United States. N Engl J Med. 1980 Feb 7;302(6):305–309. doi: 10.1056/NEJM198002073020601. [DOI] [PubMed] [Google Scholar]
  24. Blake P. A., Rosenberg M. L., Florencia J., Costa J. B., do Prado Quintino L., Gangarosa E. J. Cholera in Portugal, 1974. II. Transmission by bottled mineral water. Am J Epidemiol. 1977 Apr;105(4):344–348. doi: 10.1093/oxfordjournals.aje.a112392. [DOI] [PubMed] [Google Scholar]
  25. Bottone E. J. Yersinia enterocolitica: a panoramic view of a charismatic microorganism. CRC Crit Rev Microbiol. 1977;5(2):211–241. doi: 10.3109/10408417709102312. [DOI] [PubMed] [Google Scholar]
  26. Buchanan T. M., Eschenbach D. A., Knapp J. S., Holmes K. K. Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am J Obstet Gynecol. 1980 Dec 1;138(7 Pt 2):978–980. doi: 10.1016/0002-9378(80)91091-1. [DOI] [PubMed] [Google Scholar]
  27. Burgess M. N., Bywater R. J., Cowley C. M., Mullan N. A., Newsome P. M. Biological evaluation of a methanol-soluble, heat-stable Escherichia coli enterotoxin in infant mice, pigs, rabbits, and calves. Infect Immun. 1978 Aug;21(2):526–531. doi: 10.1128/iai.21.2.526-531.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Butzler J. P., Skirrow M. B. Campylobacter enteritis. Clin Gastroenterol. 1979 Sep;8(3):737–765. [PubMed] [Google Scholar]
  29. CLARK W. R., McLAUGHLIN J., WEBSTER M. E. An aminohexuronic acid as the principal hydrolytic component of the Vi antigen. J Biol Chem. 1958 Jan;230(1):81–89. [PubMed] [Google Scholar]
  30. CVJETANOVIC B., UEMURA K. THE PRESENT STATUS OF FIELD AND LABORATORY STUDIES OF TYPHOID AND PARATYPHOID VACCINES WITH SPECIAL REFERENCE TO STUDIES SPONSORED BY WORLD HEALTH ORGANIZATION. Bull World Health Organ. 1965;32:29–36. [PMC free article] [PubMed] [Google Scholar]
  31. Carpenter C. C. Cholera and other enterotoxin-related diarrheal diseases. J Infect Dis. 1972 Nov;126(5):551–564. doi: 10.1093/infdis/126.5.551. [DOI] [PubMed] [Google Scholar]
  32. Carter P. B., Collins F. M. The route of enteric infection in normal mice. J Exp Med. 1974 May 1;139(5):1189–1203. doi: 10.1084/jem.139.5.1189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Cash R. A., Music S. I., Libonati J. P., Craig J. P., Pierce N. F., Hornick R. B. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis. 1974 Oct;130(4):325–333. doi: 10.1093/infdis/130.4.325. [DOI] [PubMed] [Google Scholar]
  34. Cash R. A., Music S. I., Libonati J. P., Schwartz A. R., Hornick R. B. Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans. Infect Immun. 1974 Oct;10(4):762–764. doi: 10.1128/iai.10.4.762-764.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Chaicumpa W., Atthasisiha N. Study of intestinal immunity against V. cholerae: role of antibody to V. cholerae haemagglutinin in intestinal immunity. Southeast Asian J Trop Med Public Health. 1977 Mar;8(1):13–18. [PubMed] [Google Scholar]
  36. Challacombe S. J., Tomasi T. B., Jr Systemic tolerance and secretory immunity after oral immunization. J Exp Med. 1980 Dec 1;152(6):1459–1472. doi: 10.1084/jem.152.6.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Charney A. N., Gots R. E., Formal S. B., Giannella R. A. Activation of intestinal mucosal adenylate cyclase by Shigella dysenteriae I enterotoxin. Gastroenterology. 1976 Jun;70(6):1085–1090. [PubMed] [Google Scholar]
  38. Chitnis D. S., Sharma K. D., Kamat R. S. Role of somatic antigen of Vibrio cholerae in adhesion to intestinal mucosa. J Med Microbiol. 1982 Feb;15(1):53–61. doi: 10.1099/00222615-15-1-53. [DOI] [PubMed] [Google Scholar]
  39. Clegg S., Evans D. G., Evans D. J., Jr Enzyme-linked immunosorbent assay for quantitating the humoral immune response to the colonization factor antigen of enterotoxigenic Escherichia coli. Infect Immun. 1980 Feb;27(2):525–531. doi: 10.1128/iai.27.2.525-531.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Clements J. D., Finkelstein R. A. Demonstration of shared and unique immunological determinants in enterotoxins from Vibrio cholerae and Escherichia coli. Infect Immun. 1978 Dec;22(3):709–713. doi: 10.1128/iai.22.3.709-713.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Clements J. D., Flint D. C., Engert R. F., Klipstein F. A. Cloning and molecular characterization of the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun. 1983 May;40(2):653–658. doi: 10.1128/iai.40.2.653-658.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Clements J. D., Yancey R. J., Finkelstein R. A. Properties of homogeneous heat-labile enterotoxin from Escherichia coli. Infect Immun. 1980 Jul;29(1):91–97. doi: 10.1128/iai.29.1.91-97.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Clements M. L., Levine M. M., Young C. R., Black R. E., Lim Y. L., Robins-Browne R. M., Craig J. P. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis. 1982 Apr;145(4):465–473. doi: 10.1093/infdis/145.4.465. [DOI] [PubMed] [Google Scholar]
  44. Collins F. M., Carter P. B. Comparative immunogenicity of heat-killed and living oral Salmonella vaccines. Infect Immun. 1972 Oct;6(4):451–458. doi: 10.1128/iai.6.4.451-458.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Collins F. M. Immunity to enteric infection in mice. Infect Immun. 1970 Mar;1(3):243–250. doi: 10.1128/iai.1.3.243-250.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Collins F. M., Mackaness G. B., Blanden R. V. Infection-immunity in experimental salmonellosis. J Exp Med. 1966 Oct 1;124(4):601–619. doi: 10.1084/jem.124.4.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Collins F. M. Salmonellosis in orally infected specific pathogen-free C57B1 mice. Infect Immun. 1972 Feb;5(2):191–198. doi: 10.1128/iai.5.2.191-198.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Craven D. E., Frasch C. E. Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infect Immun. 1979 Oct;26(1):110–117. doi: 10.1128/iai.26.1.110-117.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Cravioto A., Scotland S. M., Rowe B. Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans. Infect Immun. 1982 Apr;36(1):189–197. doi: 10.1128/iai.36.1.189-197.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Dallas W. S. Conformity between heat-labile toxin genes from human and porcine enterotoxigenic Escherichia coli. Infect Immun. 1983 May;40(2):647–652. doi: 10.1128/iai.40.2.647-652.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Dallas W. S., Falkow S. Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin. Nature. 1980 Dec 4;288(5790):499–501. doi: 10.1038/288499a0. [DOI] [PubMed] [Google Scholar]
  52. Dallas W. S., Falkow S. The molecular nature of heat-labile enterotoxin (LT) of escherichia coli. Nature. 1979 Feb 1;277(5695):406–407. doi: 10.1038/277406a0. [DOI] [PubMed] [Google Scholar]
  53. Dallas W. S., Gill D. M., Falkow S. Cistrons encoding Escherichia coli heat-labile toxin. J Bacteriol. 1979 Sep;139(3):850–858. doi: 10.1128/jb.139.3.850-858.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Darfeuille A., Lafeuille B., Joly B., Cluzel R. A new colonization factor antigen (CFA/III) produced by enteropathogenic Escherichia coli O128:B12. Ann Microbiol (Paris) 1983 Jan-Feb;134A(1):53–64. doi: 10.1016/0769-2609(83)90103-5. [DOI] [PubMed] [Google Scholar]
  55. Deetz T. R., Evans D. J., Jr, Evans D. G., DuPont H. L. Serologic responses to somatic O and colonization-factor antigens of enterotoxigenic Escherichia coli in travelers. J Infect Dis. 1979 Jul;140(1):114–118. doi: 10.1093/infdis/140.1.114. [DOI] [PubMed] [Google Scholar]
  56. Deneke C. F., Thorne G. M., Gorbach S. L. Serotypes of attachment pili of enterotoxigenic Escherichia coli isolated from humans. Infect Immun. 1981 Jun;32(3):1254–1260. doi: 10.1128/iai.32.3.1254-1260.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Dobrescu L., Huygelen C. Protection of piglets against neonatal E. coli enteritis by immunization of the sow with a vaccine containing heat-labile enterotoxin (LT) I. Protection against experimentally induced diarrhoea. Zentralbl Veterinarmed B. 1976 Feb;23(1):79–88. doi: 10.1111/j.1439-0450.1976.tb00655.x. [DOI] [PubMed] [Google Scholar]
  58. Donowitz M., Keusch G. T., Binder H. J. Effect of Shigella enterotoxin on electrolyte transport in rabbit ileum. Gastroenterology. 1975 Dec;69(6):1230–1237. [PubMed] [Google Scholar]
  59. Dorner F., Mayer P., Leskova R. Immunity to Escherichia coli in piglets: the role of colostral antibodies directed against heat labile enterotoxin in experimental neonatal diarrhoea. Zentralbl Veterinarmed B. 1980;27(3):207–221. doi: 10.1111/j.1439-0450.1980.tb01907.x. [DOI] [PubMed] [Google Scholar]
  60. DuPont H. L., Formal S. B., Hornick R. B., Snyder M. J., Libonati J. P., Sheahan D. G., LaBrec E. H., Kalas J. P. Pathogenesis of Escherichia coli diarrhea. N Engl J Med. 1971 Jul 1;285(1):1–9. doi: 10.1056/NEJM197107012850101. [DOI] [PubMed] [Google Scholar]
  61. DuPont H. L., Hornick R. B., Snyder M. J., Libonati J. P., Formal S. B., Gangarosa E. J. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella. J Infect Dis. 1972 Jan;125(1):5–11. doi: 10.1093/infdis/125.1.5. [DOI] [PubMed] [Google Scholar]
  62. DuPont H. L., Hornick R. B., Snyder M. J., Libonati J. P., Formal S. B., Gangarosa E. J. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection. J Infect Dis. 1972 Jan;125(1):12–16. doi: 10.1093/infdis/125.1.12. [DOI] [PubMed] [Google Scholar]
  63. DuPont H. L., Olarte J., Evans D. G., Pickering L. K., Galindo E., Evans D. J. Comparative susceptibility of latin american and united states students to enteric pathogens. N Engl J Med. 1976 Dec 30;295(27):1520–1521. doi: 10.1056/NEJM197612302952707. [DOI] [PubMed] [Google Scholar]
  64. Dutt A. K., Alwi S., Velauthan T. A shellfish-borne cholera outbreak in Malaysia. Trans R Soc Trop Med Hyg. 1971;65(6):815–818. doi: 10.1016/0035-9203(71)90097-6. [DOI] [PubMed] [Google Scholar]
  65. EDSALL G., GAINES S., LANDY M., TIGERTT W. D., SPRINZ H., TRAPANI R. J., MANDEL A. D., BENENSON A. S. Studies on infection and immunity in experimental typhoid fever. I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa. J Exp Med. 1960 Jul 1;112:143–166. doi: 10.1084/jem.112.1.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Echeverria P. D., Chang C. P., Smith D. Enterotoxigenicity and invasive capacity of "enteropathogenic" serotypes of Escherichia coli. J Pediatr. 1976 Jul;89(1):8–10. doi: 10.1016/s0022-3476(76)80917-1. [DOI] [PubMed] [Google Scholar]
  67. Echeverria P., Blacklow N. R., Sanford L. B., Cukor G. G. Travelers' diarrhea among American Peace Corps volunteers in rural Thailand. J Infect Dis. 1981 Jun;143(6):767–771. doi: 10.1093/infdis/143.6.767. [DOI] [PubMed] [Google Scholar]
  68. Echeverria P., Orskov F., Orskov I., Plianbangchang D. Serotypes of enterotoxigenic Escherichia coli in Thailand and the Philippines. Infect Immun. 1982 Jun;36(3):851–856. doi: 10.1128/iai.36.3.851-856.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Edelman R., Levine M. M. Acute diarrheal infections in infants I. Bacterial and viral causes. Hosp Pract. 1980 Jan;15(1):97–104. doi: 10.1080/21548331.1980.11946543. [DOI] [PubMed] [Google Scholar]
  70. Edelman R., Levine M. M. From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli. J Infect Dis. 1983 Jun;147(6):1108–1118. doi: 10.1093/infdis/147.6.1108. [DOI] [PubMed] [Google Scholar]
  71. Eubanks E. R., Guentzel M. N., Berry L. J. Evaluation of surface components of Vibrio cholerae as protective immunogens. Infect Immun. 1977 Feb;15(2):533–538. doi: 10.1128/iai.15.2.533-538.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Evans D. G., Evans D. J., Jr New surface-associated heat-labile colonization factor antigen (CFA/II) produced by enterotoxigenic Escherichia coli of serogroups O6 and O8. Infect Immun. 1978 Aug;21(2):638–647. doi: 10.1128/iai.21.2.638-647.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Evans D. G., Evans D. J., Jr, Tjoa W. S., DuPont H. L. Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun. 1978 Feb;19(2):727–736. doi: 10.1128/iai.19.2.727-736.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Evans D. G., Satterwhite T. K., Evans D. J., Jr, DuPont H. L. Differences in serological responses and excretion patterns of volunteers challenged with enterotoxigenic Escherichia coli with and without the colonization factor antigen. Infect Immun. 1978 Mar;19(3):883–888. doi: 10.1128/iai.19.3.883-888.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Evans D. G., Silver R. P., Evans D. J., Jr, Chase D. G., Gorbach S. L. Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans. Infect Immun. 1975 Sep;12(3):656–667. doi: 10.1128/iai.12.3.656-667.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Evans D. G., de la Cabada F. J., Evans D. J., Jr Correlation between intestinal immune response to colonization factor antigen/I and acquired resistance to enterotoxigenic Escherichia coli diarrhea in an adult rabbit model. Eur J Clin Microbiol. 1982 Jun;1(3):178–185. doi: 10.1007/BF02019620. [DOI] [PubMed] [Google Scholar]
  77. Evans D. J., Jr, Evans D. G., DuPont H. L., Orskov F., Orskov I. Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun. 1977 Jul;17(1):105–111. doi: 10.1128/iai.17.1.105-111.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. FALKOW S., SCHNEIDER H., BARON L. S., FORMAL S. B. VIRULENCE OF ESCHERICHIA-SHIGELLA GENETIC HYBRIDS FOR THE GUINEA PIG. J Bacteriol. 1963 Dec;86:1251–1258. doi: 10.1128/jb.86.6.1251-1258.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. FELIX A., ANDERSON E. S. Bacteriophage, virulence and agglutination tests with a strain of Salmonella typhi of low virulence. J Hyg (Lond) 1951 Jun-Sep;49(2-3):349–364. doi: 10.1017/s0022172400044211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. FERGUSON W. W., JUNE R. C. Experiments on feeding adult volunteers with Escherichia coli 111, B4, a coliform organism associated with infant diarrhea. Am J Hyg. 1952 Mar;55(2):155–169. doi: 10.1093/oxfordjournals.aje.a119510. [DOI] [PubMed] [Google Scholar]
  81. FOLLETT E. A., GORDON J. AN ELECTRON MICROSCOPE STUDY OF VIBRIO FLAGELLA. J Gen Microbiol. 1963 Aug;32:235–239. doi: 10.1099/00221287-32-2-235. [DOI] [PubMed] [Google Scholar]
  82. FORMAL S. B., ABRAMS G. D., SCHNEIDER H., SPRINZ H. Experimental Shigella infections. VI. Role of the small intestine in an experimental infection in guinea pigs. J Bacteriol. 1963 Jan;85:119–125. doi: 10.1128/jb.85.1.119-125.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. FORMAL S. B., LABREC E. H., KENT T. H., FALKOW S. ABORTIVE INTESTINAL INFECTION WITH AN ESCHERICHIA COLI-SHIGELLA FLEXNERI HYBRID STRAIN. J Bacteriol. 1965 May;89:1374–1382. doi: 10.1128/jb.89.5.1374-1382.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. FRETER R., GANGAROSA E. J. ORAL IMMUNIZATION AND PRODUCTION OF COPROANTIBODY IN HUMAN VOLUNTEERS. J Immunol. 1963 Dec;91:724–729. [PubMed] [Google Scholar]
  85. FRETER R. The serologic character of cholera Vibrio mucinase. J Infect Dis. 1955 Nov-Dec;97(3):238–245. doi: 10.1093/infdis/97.3.238. [DOI] [PubMed] [Google Scholar]
  86. Fernandes P. B., Kim C., Cundy K. R., Haung N. N. Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients. Infect Immun. 1981 Aug;33(2):527–532. doi: 10.1128/iai.33.2.527-532.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Field M., Graf L. H., Jr, Laird W. J., Smith P. L. Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2800–2804. doi: 10.1073/pnas.75.6.2800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Field M. Mechanisms of action of cholera and Escherichia coli enterotoxins. Am J Clin Nutr. 1979 Jan;32(1):189–196. doi: 10.1093/ajcn/32.1.189. [DOI] [PubMed] [Google Scholar]
  89. Finkelstein R. A., Boesman-Finkelstein M., Holt P. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A. 1983 Feb;80(4):1092–1095. doi: 10.1073/pnas.80.4.1092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Finkelstein R. A., Fujita K., LoSpalluto J. J. Procholeragenoid: an aggregated intermediate in the formation of choleragenoid. J Immunol. 1971 Oct;107(4):1043–1051. [PubMed] [Google Scholar]
  91. Finkelstein R. A., Hanne L. F. Purification and characterization of the soluble hemagglutinin (cholera lectin)( produced by Vibrio cholerae. Infect Immun. 1982 Jun;36(3):1199–1208. doi: 10.1128/iai.36.3.1199-1208.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Finkelstein R. A., Vasil M. L., Holmes R. K. Studies on toxinogenesis in Vibrio cholerae. I. Isolation of mutants with altered toxinogenicity. J Infect Dis. 1974 Feb;129(2):117–123. doi: 10.1093/infdis/129.2.117. [DOI] [PubMed] [Google Scholar]
  93. Flores J., Grady G. F., McIver J., Witkum P., Beckman B., Sharp G. W. Comparison of the effects of enterotoxins of Shigella dysenteriae and Vibrio cholerae on the adenylate cyclase system of the rabbit intestine. J Infect Dis. 1974 Oct;130(4):374–379. doi: 10.1093/infdis/130.4.374. [DOI] [PubMed] [Google Scholar]
  94. Formal S. B., Baron L. S., Kopecko D. J., Washington O., Powell C., Life C. A. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun. 1981 Dec;34(3):746–750. doi: 10.1128/iai.34.3.746-750.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Formal S. B., Gemski P., Baron L. S., Labrec E. H. A Chromosomal Locus Which Controls the Ability of Shigella flexneri to Evoke Keratoconjunctivitis. Infect Immun. 1971 Jan;3(1):73–79. doi: 10.1128/iai.3.1.73-79.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Formal S. B., Maenza R. M., Austin S., LaBrec E. H. Failure of parenteral vaccines to protect monkeys against experimental shigellosis. Proc Soc Exp Biol Med. 1967 Jun;125(2):347–349. doi: 10.3181/00379727-125-32087. [DOI] [PubMed] [Google Scholar]
  97. Freter R., Allweiss B., O'Brien P. C., Halstead S. A., Macsai M. S. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect Immun. 1981 Oct;34(1):241–249. doi: 10.1128/iai.34.1.241-249.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Freter R., Jones G. W. Adhesive properties of Vibrio cholerae: nature of the interaction with intact mucosal surfaces. Infect Immun. 1976 Jul;14(1):246–256. doi: 10.1128/iai.14.1.246-256.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Freter R., O'Brien P. C., Macsai M. S. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect Immun. 1981 Oct;34(1):234–240. doi: 10.1128/iai.34.1.234-240.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Freter R., O'Brien P. C. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: chemotactic responses of Vibrio cholerae and description of motile nonchemotactic mutants. Infect Immun. 1981 Oct;34(1):215–221. doi: 10.1128/iai.34.1.215-221.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Freter R., O'Brien P. C. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect Immun. 1981 Oct;34(1):222–233. doi: 10.1128/iai.34.1.222-233.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Fujita K., Finkelstein R. A. Antitoxic immunity in experimental cholera: comparison of immunity induced perorally and parenterally in mice. J Infect Dis. 1972 Jun;125(6):647–655. doi: 10.1093/infdis/125.6.647. [DOI] [PubMed] [Google Scholar]
  103. Fürer E., Cryz S. J., Jr, Dorner F., Nicolet J., Wanner M., Germanier R. Protection against colibacillosis in neonatal piglets by immunization of dams with procholeragenoid. Infect Immun. 1982 Mar;35(3):887–894. doi: 10.1128/iai.35.3.887-894.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. GERICHTER C. B. The dissemination of Salmonella typhi, S. paratyphi A and S. paratyphi B through the organs of the white mouse by oral infection. J Hyg (Lond) 1960 Sep;58:307–319. doi: 10.1017/s0022172400038420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Gaines S., Sprinz H., Tully J. G., Tigertt W. D. Studies on infection and immunity in experimental typhoid fever. VII. The distribution of Salmonella typhi in chimpanzee tissue following oral challenge, and the relationship between the numbers of bacilli and morphologic lesions. J Infect Dis. 1968 Jun;118(3):293–306. doi: 10.1093/infdis/118.3.293. [DOI] [PubMed] [Google Scholar]
  106. Ganguly R., Clem L. W., Bencić Z., Sinha R., Sakazaki R., Waldman R. H. Antibody response in the intestinal secretions of volunteers immunized with various cholera vaccines. Bull World Health Organ. 1975;52(3):323–330. [PMC free article] [PubMed] [Google Scholar]
  107. Geary S. J., Marchlewicz B. A., Finkelstein R. A. Comparison of heat-labile enterotoxins from porcine and human strains of Escherichia coli. Infect Immun. 1982 Apr;36(1):215–220. doi: 10.1128/iai.36.1.215-220.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Gemski P., Jr, Sheahan D. G., Washington O., Formal S. B. Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens. Infect Immun. 1972 Aug;6(2):104–111. doi: 10.1128/iai.6.2.104-111.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Germanier R., Füer E. Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine. J Infect Dis. 1975 May;131(5):553–558. doi: 10.1093/infdis/131.5.553. [DOI] [PubMed] [Google Scholar]
  110. Germanier R., Fürer E. Immunity in experimental salmonellosis. II. Basis for the avirulence and protective capacity of gal E mutants of Salmonella typhimurium. Infect Immun. 1971 Dec;4(6):663–673. doi: 10.1128/iai.4.6.663-673.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Germanier R., Fürer E., Varallyay S., Inderbitzin T. M. Antigenicity of cholera toxoid in humans. J Infect Dis. 1977 Apr;135(4):512–516. doi: 10.1093/infdis/135.4.512. [DOI] [PubMed] [Google Scholar]
  112. Germanier R., Fürer E., Varallyay S., Inderbitzin T. M. Preparation of a purified antigenic cholera toxoid. Infect Immun. 1976 Jun;13(6):1692–1698. doi: 10.1128/iai.13.6.1692-1698.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Germanier R. Immunity in Experimental Salmonellosis I. Protection Induced by Rough Mutants of Salmonella typhimurium. Infect Immun. 1970 Sep;2(3):309–315. doi: 10.1128/iai.2.3.309-315.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Germanier R. Immunity in experimental salmonellosis. 3. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium. Infect Immun. 1972 May;5(5):792–797. doi: 10.1128/iai.5.5.792-797.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Giannella R. A., Drake K. W. Effect of purified Escherichia coli heat-stable enterotoxin on intestinal cyclic nucleotide metabolism and fluid secretion. Infect Immun. 1979 Apr;24(1):19–23. doi: 10.1128/iai.24.1.19-23.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. Giannella R. A., Drake K. W., Luttrell M. Development of a radioimmunoassay for Escherichia coli heat-stable enterotoxin: comparison with the suckling mouse bioassay. Infect Immun. 1981 Jul;33(1):186–192. doi: 10.1128/iai.33.1.186-192.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Giannella R. A., Formal S. B., Dammin G. J., Collins H. Pathogenesis of salmonellosis. Studies of fluid secretion, mucosal invasion, and morphologic reaction in the rabbit ileum. J Clin Invest. 1973 Feb;52(2):441–453. doi: 10.1172/JCI107201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Giannella R. A., Washington O., Gemski P., Formal S. B. Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J Infect Dis. 1973 Jul;128(1):69–75. doi: 10.1093/infdis/128.1.69. [DOI] [PubMed] [Google Scholar]
  119. Gill D. M. Mechanism of action of cholera toxin. Adv Cyclic Nucleotide Res. 1977;8:85–118. [PubMed] [Google Scholar]
  120. Gill D. M., Richardson S. H. Adenosine diphosphate-ribosylation of adenylate cyclase catalyzed by heat-labile enterotoxin of Escherichia coli: comparison with cholera toxin. J Infect Dis. 1980 Jan;141(1):64–70. doi: 10.1093/infdis/141.1.64. [DOI] [PubMed] [Google Scholar]
  121. Gilman R. H., Hornick R. B., Woodard W. E., DuPont H. L., Snyder M. J., Levine M. M., Libonati J. P. Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis. 1977 Dec;136(6):717–723. doi: 10.1093/infdis/136.6.717. [DOI] [PubMed] [Google Scholar]
  122. Glass R. I., Becker S., Huq M. I., Stoll B. J., Khan M. U., Merson M. H., Lee J. V., Black R. E. Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol. 1982 Dec;116(6):959–970. doi: 10.1093/oxfordjournals.aje.a113498. [DOI] [PubMed] [Google Scholar]
  123. Goldschmidt M. C., DuPont H. L. Enteropathogenic Escherichia coli: lack of correlation of serotype with pathogenicity. J Infect Dis. 1976 Feb;133(2):153–156. doi: 10.1093/infdis/133.2.153. [DOI] [PubMed] [Google Scholar]
  124. Goodgame R. W., Greenough W. B. Cholera in Africa: a message for the West. Ann Intern Med. 1975 Jan;82(1):101–106. doi: 10.7326/0003-4819-82-1-101. [DOI] [PubMed] [Google Scholar]
  125. Gorbach S. L., Kean B. H., Evans D. G., Evans D. J., Jr, Bessudo D. Travelers' diarrhea and toxigenic Escherichia coli. N Engl J Med. 1975 May 1;292(18):933–936. doi: 10.1056/NEJM197505012921801. [DOI] [PubMed] [Google Scholar]
  126. Greenberg H. B., Levine M. M., Merson M. H., Sack R. B., Sack D. A., Valdesuso J. R., Nalin D., Hoover D., Chanock R. M., Kapikian A. Z. Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin. J Clin Microbiol. 1979 Jan;9(1):60–64. doi: 10.1128/jcm.9.1.60-64.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Gross R. J., Scotland S. M., Rowe B. Enterotoxin testing of Escherichia coli causing epidemic infantile enteritis in the U.K. Lancet. 1976 Mar 20;1(7960):629–631. doi: 10.1016/s0140-6736(76)90429-3. [DOI] [PubMed] [Google Scholar]
  128. Guentzel M. N., Amerine D., Guerrero D., Gay T. V. Association of Vibrio cholerae mutants with the intestinal mucosa of infant mice. Scan Electron Microsc. 1981;4:115–124. [PubMed] [Google Scholar]
  129. Guentzel M. N., Berry L. J. Motility as a virulence factor for Vibrio cholerae. Infect Immun. 1975 May;11(5):890–897. doi: 10.1128/iai.11.5.890-897.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Guentzel M. N., Field L. H., Eubanks E. R., Berry L. J. Use of fluorescent antibody in studies of immunity to cholera in infant mice. Infect Immun. 1977 Feb;15(2):539–548. doi: 10.1128/iai.15.2.539-548.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Guerrant R. L., Hughes J. M., Chang B., Robertson D. C., Murad F. Activation of intestinal guanylate cyclase by heat-stable enterotoxin of Escherichia coli: studies of tissue specificity, potential receptors, and intermediates. J Infect Dis. 1980 Aug;142(2):220–228. doi: 10.1093/infdis/142.2.220. [DOI] [PubMed] [Google Scholar]
  132. Guerrant R. L., Rouse J. D., Hughes J. M., Rowe B. Turista among members of the Yale Glee Club in Latin America. Am J Trop Med Hyg. 1980 Sep;29(5):895–900. doi: 10.4269/ajtmh.1980.29.895. [DOI] [PubMed] [Google Scholar]
  133. Guinée P. A., Agterberg C. M., Jansen W. H., Frik J. F. Serological identification of pig enterotoxigenic Escherichia coli strains not belonging to the classical serotypes. Infect Immun. 1977 Feb;15(2):549–555. doi: 10.1128/iai.15.2.549-555.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Gulig P. A., McCracken G. H., Jr, Frisch C. F., Johnston K. H., Hansen E. J. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun. 1982 Jul;37(1):82–88. doi: 10.1128/iai.37.1.82-88.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Gurwith M. J., Wiseman D. A., Chow P. Clinical and laboratory assessment of the pathogenicity of serotyped enteropathogenic Escherichia coli. J Infect Dis. 1977 May;135(5):735–743. [PubMed] [Google Scholar]
  136. Gyles C., So M., Falkow S. The enterotoxin plasmids of Escherichia coli. J Infect Dis. 1974 Jul;130(1):40–49. doi: 10.1093/infdis/130.1.40. [DOI] [PubMed] [Google Scholar]
  137. HARDY A. V., DECAPITO T., HALBERT S. P. Studies of the acute diarrheal diseases; immunization in shigellosis. Public Health Rep. 1948 May 21;63(21):685–688. [PubMed] [Google Scholar]
  138. HIGGINS A. R., FLOYD T. M., KADER M. A. Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment. Am J Trop Med Hyg. 1955 Mar;4(2):281–288. [PubMed] [Google Scholar]
  139. Hale T. L., Bonventre P. F. Shigella infection of Henle intestinal epithelial cells: role of the bacterium. Infect Immun. 1979 Jun;24(3):879–886. doi: 10.1128/iai.24.3.879-886.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Hale T. L., Morris R. E., Bonventre P. F. Shigella infection of henle intestinal epithelial cells: role of the host cell. Infect Immun. 1979 Jun;24(3):887–894. doi: 10.1128/iai.24.3.887-894.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Hale T. L., Sansonetti P. J., Schad P. A., Austin S., Formal S. B. Characterization of virulence plasmids and plasmid-associated outer membrane proteins in Shigella flexneri, Shigella sonnei, and Escherichia coli. Infect Immun. 1983 Apr;40(1):340–350. doi: 10.1128/iai.40.1.340-350.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Hanne L. F., Finkelstein R. A. Characterization and distribution of the hemagglutinins produced by Vibrio cholerae. Infect Immun. 1982 Apr;36(1):209–214. doi: 10.1128/iai.36.1.209-214.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Hansen E. J., Frisch C. F., McDade R. L., Jr, Johnston K. H. Identification of immunogenic outer membrane proteins of Haemophilus influenzae type b in the infant rat model system. Infect Immun. 1981 Jun;32(3):1084–1092. doi: 10.1128/iai.32.3.1084-1092.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Hejfec L. B., Salmin L. V., Lejtman M. Z., Kuz'minova M. L., Vasil'eva A. V., Levina L. A., Bencianova T. G., Pavlova E. A., Antonova A. A. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull World Health Organ. 1966;34(3):321–339. [PMC free article] [PubMed] [Google Scholar]
  145. Hisatsune K., Kondo S., Kawata T., Kishimoto Y. Fatty acid composition of lipopolysaccharides of Vibrio cholerae 35A3 (Inaba), NIB 90 (Ogawa), and 4715 (Nag). J Bacteriol. 1979 Apr;138(1):288–290. doi: 10.1128/jb.138.1.288-290.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Hohmann A., Schmidt G., Rowley D. Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains. Infect Immun. 1979 Jul;25(1):27–33. doi: 10.1128/iai.25.1.27-33.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Hoiseth S. K., Stocker B. A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 1981 May 21;291(5812):238–239. doi: 10.1038/291238a0. [DOI] [PubMed] [Google Scholar]
  148. Holmes R. K., Vasil M. L., Finkelstein R. A. Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals. J Clin Invest. 1975 Mar;55(3):551–560. doi: 10.1172/JCI107962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature. 1981 Jul 30;292(5822):413–417. doi: 10.1038/292413a0. [DOI] [PubMed] [Google Scholar]
  150. Holmgren J. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect Immun. 1973 Dec;8(6):851–859. doi: 10.1128/iai.8.6.851-859.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Holmgren J., Fredman P., Lindblad M., Svennerholm A. M., Svennerholm L. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun. 1982 Nov;38(2):424–433. doi: 10.1128/iai.38.2.424-433.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Holmgren J., Svennerholm A. M., Lindblad M. Receptor-like glycocompounds in human milk that inhibit classical and El Tor Vibrio cholerae cell adherence (hemagglutination). Infect Immun. 1983 Jan;39(1):147–154. doi: 10.1128/iai.39.1.147-154.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Holmgren J., Svennerholm A. M. Mechanisms of disease and immunity in cholera: a review. J Infect Dis. 1977 Aug;136 (Suppl):S105–S112. doi: 10.1093/infdis/136.supplement.s105. [DOI] [PubMed] [Google Scholar]
  154. Honda T., Finkelstein R. A. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin. Proc Natl Acad Sci U S A. 1979 Apr;76(4):2052–2056. doi: 10.1073/pnas.76.4.2052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Honda T., Tsuji T., Takeda Y., Miwatani T. Immunological nonidentity of heat-labile enterotoxins from human and porcine enterotoxigenic Escherichia coli. Infect Immun. 1981 Nov;34(2):337–340. doi: 10.1128/iai.34.2.337-340.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Hornick R. B., Greisman S. E., Woodward T. E., DuPont H. L., Dawkins A. T., Snyder M. J. Typhoid fever: pathogenesis and immunologic control. 2. N Engl J Med. 1970 Oct 1;283(14):739–746. doi: 10.1056/NEJM197010012831406. [DOI] [PubMed] [Google Scholar]
  157. Hornick R. B., Greisman S. E., Woodward T. E., DuPont H. L., Dawkins A. T., Snyder M. J. Typhoid fever: pathogenesis and immunologic control. N Engl J Med. 1970 Sep 24;283(13):686–691. doi: 10.1056/NEJM197009242831306. [DOI] [PubMed] [Google Scholar]
  158. Hranitzky K. W., Mulholland A., Larson A. D., Eubanks E. R., Hart L. T. Characterization of a flagellar sheath protein of Vibrio cholerae. Infect Immun. 1980 Feb;27(2):597–603. doi: 10.1128/iai.27.2.597-603.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Hughes J. M., Boyce J. M., Levine R. J., Khan M., Aziz K. M., Huq M. I., Curlin G. T. Epidemiology of eltor cholera in rural Bangladesh: importance of surface water in transmission. Bull World Health Organ. 1982;60(3):395–404. [PMC free article] [PubMed] [Google Scholar]
  160. Isaacson R. E., Fusco P. C., Brinton C. C., Moon H. W. In vitro adhesion of Escherichia coli to porcine small intestinal epithelial cells: pili as adhesive factors. Infect Immun. 1978 Aug;21(2):392–397. doi: 10.1128/iai.21.2.392-397.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Isaacson R. E., Nagy B., Moon H. W. Colonization of porcine small intestine by Escherichia coli: colonization and adhesion factors of pig enteropathogens that lack K88. J Infect Dis. 1977 Apr;135(4):531–539. doi: 10.1093/infdis/135.4.531. [DOI] [PubMed] [Google Scholar]
  162. Istrati G., Meitert T., Ciufecu C. Transformation von Shigellen in Stämme, die für den Menschen und für das Meerschweinchenauge apathogen sind. Zentralbl Bakteriol Orig. 1967;203(3):295–299. [PubMed] [Google Scholar]
  163. JUNE R. C., FERGUSON W. W., WORFEL M. T. Experiments in feeding adult volunteers with Escherichia coli 55, B5, a coliform organism associated with infant diarrhea. Am J Hyg. 1953 Mar;57(2):222–236. doi: 10.1093/oxfordjournals.aje.a119570. [DOI] [PubMed] [Google Scholar]
  164. Jones G. W., Abrams G. D., Freter R. Adhesive properties of Vibrio cholerae: adhesion to isolated rabbit brush border membranes and hemagglutinating activity. Infect Immun. 1976 Jul;14(1):232–239. doi: 10.1128/iai.14.1.232-239.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Jones G. W., Freter R. Adhesive properties of Vibrio cholerae: nature of the interaction with isolated rabbit brush border membranes and human erythrocytes. Infect Immun. 1976 Jul;14(1):240–245. doi: 10.1128/iai.14.1.240-245.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. KAUFFMANN F., DUPONT A. Escherichia strains from infantile epidemic gastro enteritis. Acta Pathol Microbiol Scand. 1950;27(4):552–564. doi: 10.1111/j.1699-0463.1950.tb04927.x. [DOI] [PubMed] [Google Scholar]
  167. KIRBY A. C., HALL E. G., COACKLEY W. Neonatal diarrhoea and vomiting; outbreaks in the same maternity unit. Lancet. 1950 Aug 5;2(6623):201–207. doi: 10.1016/s0140-6736(50)91189-5. [DOI] [PubMed] [Google Scholar]
  168. KOYA G., KOSAKAI N., FUKASAWA Y. Supplementary studies on the multiplication of Escherichia coli O-111 B4 in the intestinal tract of adult volunteers and its relation to manifestation of coli enteritis. Jpn J Med Sci Biol. 1954 Dec;7(6):655–661. doi: 10.7883/yoken1952.7.655. [DOI] [PubMed] [Google Scholar]
  169. KOYA G., KOSAKAI N., KONO M., MORI M., FUKASAWA Y. Observations on the multiplication of Escherichia coli 0-111 B4 in the intestinal tract of adult volunteers in feeding experiments, the intubation study with Miller-Abbott's double lumen tube. Jpn J Med Sci Biol. 1954 Apr;7(2):197–203. doi: 10.7883/yoken1952.7.197. [DOI] [PubMed] [Google Scholar]
  170. Kabir S., Ali S. Characterization of surface properties of Vibrio cholerae. Infect Immun. 1983 Mar;39(3):1048–1058. doi: 10.1128/iai.39.3.1048-1058.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Kabir S. Characterization of the lipopolysaccharide from Vibrio cholerae 395 (Ogawa). Infect Immun. 1982 Dec;38(3):1263–1272. doi: 10.1128/iai.38.3.1263-1272.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Kabir S. Composition and immunochemical properties of outer membrane proteins of Vibrio cholerae. J Bacteriol. 1980 Oct;144(1):382–389. doi: 10.1128/jb.144.1.382-389.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Kabir S. Immunochemical properties of the major outer membrane protein of Vibrio cholerae. Infect Immun. 1983 Jan;39(1):452–455. doi: 10.1128/iai.39.1.452-455.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Kaper J. B., Levine M. M. Cloned cholera enterotoxin genes in study and prevention of cholera. Lancet. 1981 Nov 21;2(8256):1162–1163. doi: 10.1016/s0140-6736(81)90605-x. [DOI] [PubMed] [Google Scholar]
  175. Kelley J. T., Parker C. D. Identification and preliminary characterization of Vibrio cholerae outer membrane proteins. J Bacteriol. 1981 Feb;145(2):1018–1024. doi: 10.1128/jb.145.2.1018-1024.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Kenne L., Lindberg B., Unger P., Gustafsson B., Holme T. Structural studies of the Vibrio cholerae O-antigen. Carbohydr Res. 1982 Mar 1;100:341–349. doi: 10.1016/s0008-6215(00)81047-2. [DOI] [PubMed] [Google Scholar]
  177. Kent T. H., Formal S. B., Labrec E. H. Acute enteritis due to Salmonella typhimurium in opium-treated guinea pigs. Arch Pathol. 1966 Jun;81(6):501–508. [PubMed] [Google Scholar]
  178. Kent T. H., Formal S. B., Labrec E. H. Salmonella gastroenteritis in rhesus monkeys. Arch Pathol. 1966 Sep;82(3):272–279. [PubMed] [Google Scholar]
  179. Keusch G. T., Donohue-Rolfe A., Jacewicz M. Shigella toxin(s): description and role in diarrhea and dysentery. Pharmacol Ther. 1981;15(3):403–438. doi: 10.1016/0163-7258(81)90052-8. [DOI] [PubMed] [Google Scholar]
  180. Keusch G. T., Grady G. F., Mata L. J., McIver J. The pathogenesis of Shigella diarrhea. I. Enterotoxin production by Shigella dysenteriae I. J Clin Invest. 1972 May;51(5):1212–1218. doi: 10.1172/JCI106915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Keusch G. T., Jacewicz M. The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans. J Infect Dis. 1977 Apr;135(4):552–556. doi: 10.1093/infdis/135.4.552. [DOI] [PubMed] [Google Scholar]
  182. Klipstein F. A., Engert R. F., Clements J. D. Development of a vaccine of cross-linked heat-stable and heat-labile enterotoxins that protects against Escherichia coli producing either enterotoxin. Infect Immun. 1982 Aug;37(2):550–557. doi: 10.1128/iai.37.2.550-557.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Klipstein F. A., Engert R. F., Clements J. D., Houghten R. A. Protection against human and porcine enterotoxigenic strains of Escherichia coli in rats immunized with a cross-linked toxoid vaccine. Infect Immun. 1983 Jun;40(3):924–929. doi: 10.1128/iai.40.3.924-929.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Klipstein F. A., Engert R. F., Clements J. D., Houghten R. A. Vaccine for enterotoxigenic Escherichia coli based on synthetic heat-stable toxin crossed-linked to the B subunit of heat-labile toxin. J Infect Dis. 1983 Feb;147(2):318–326. doi: 10.1093/infdis/147.2.318. [DOI] [PubMed] [Google Scholar]
  185. Klipstein F. A., Engert R. F., Clements J. D. Protection in rats immunized with Escherichia coli heat-stable enterotoxin. Infect Immun. 1981 Nov;34(2):637–639. doi: 10.1128/iai.34.2.637-639.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Klipstein F. A., Engert R. F., Houghten R. A. Properties of synthetically produced Escherichia coli heat-stable enterotoxin. Infect Immun. 1983 Jan;39(1):117–121. doi: 10.1128/iai.39.1.117-121.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Klipstein F. A., Engert R. F., Houghten R. A. Protection in rabbits immunized with a vaccine of Escherichia coli heat-stable toxin cross-linked to the heat-labile toxin B subunit. Infect Immun. 1983 Jun;40(3):888–893. doi: 10.1128/iai.40.3.888-893.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Klipstein F. A., Engert R. F. Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun. 1981 Jan;31(1):144–150. doi: 10.1128/iai.31.1.144-150.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Klipstein F. A., Rowe B., Engert R. F., Short H. B., Gross R. J. Enterotoxigenicity of enteropathogenic serotypes of Escherichia coli isolated from infants with epidemic diarrhea. Infect Immun. 1978 Jul;21(1):171–178. doi: 10.1128/iai.21.1.171-178.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Kohl S. Yersinia enterocolitica infections in children. Pediatr Clin North Am. 1979 May;26(2):433–443. doi: 10.1016/s0031-3955(16)33715-4. [DOI] [PubMed] [Google Scholar]
  191. Kopecko D. J., Washington O., Formal S. B. Genetic and physical evidence for plasmid control of Shigella sonnei form I cell surface antigen. Infect Immun. 1980 Jul;29(1):207–214. doi: 10.1128/iai.29.1.207-214.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Kubinyi L., Kiss I., Lendvai K. G. Epidemiological evaluation of the efficiency of oral vaccination against enteropathogenic Escherichia coli. Acta Microbiol Acad Sci Hung. 1972;19(3):175–186. [PubMed] [Google Scholar]
  193. Kubinyi L., Kiss I., Lendvai K. G. Epidemiological-statistical evaluation of oral vaccination against infantile escherichia coli enteritis. Acta Microbiol Acad Sci Hung. 1974;21(1-2):187–191. [PubMed] [Google Scholar]
  194. Kunkel S. L., Robertson D. C. Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli. Infect Immun. 1979 Aug;25(2):586–596. doi: 10.1128/iai.25.2.586-596.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. LAM G. T., MANDLE R. J., GOODNER K. The effect of Vibrio comma mucinase upon the permeability of mouse intestine. J Infect Dis. 1955 Nov-Dec;97(3):268–273. doi: 10.1093/infdis/97.3.268. [DOI] [PubMed] [Google Scholar]
  196. Labrec E. H., Schneider H., Magnani T. J., Formal S. B. EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY. J Bacteriol. 1964 Nov;88(5):1503–1518. doi: 10.1128/jb.88.5.1503-1518.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Lange S., Holmgren J. Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies. Acta Pathol Microbiol Scand C. 1978 Aug;86C(4):145–152. doi: 10.1111/j.1699-0463.1978.tb02572.x. [DOI] [PubMed] [Google Scholar]
  198. Levin D. M., Wong K. H., Reynolds H. Y., Sutton A., Northrup R. S. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans. Infect Immun. 1975 Dec;12(6):1290–1294. doi: 10.1128/iai.12.6.1290-1294.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Levine M. M. Adhesion of enterotoxigenic Escherichia coli in humans and animals. Ciba Found Symp. 1981;80:142–160. doi: 10.1002/9780470720639.ch10. [DOI] [PubMed] [Google Scholar]
  200. Levine M. M. Bacillary dysentery: mechanisms and treatment. Med Clin North Am. 1982 May;66(3):623–638. doi: 10.1016/s0025-7125(16)31411-0. [DOI] [PubMed] [Google Scholar]
  201. Levine M. M., Bergquist E. J., Nalin D. R., Waterman D. H., Hornick R. B., Young C. R., Sotman S. Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet. 1978 May 27;1(8074):1119–1122. doi: 10.1016/s0140-6736(78)90299-4. [DOI] [PubMed] [Google Scholar]
  202. Levine M. M., Black R. E., Brinton C. C., Jr, Clements M. L., Fusco P., Hughes T. P., O'Donnell S., Robins-Browne R., Wood S., Young C. R. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man. Scand J Infect Dis Suppl. 1982;33:83–95. [PubMed] [Google Scholar]
  203. Levine M. M., Black R. E., Clements M. L., Cisneros L., Nalin D. R., Young C. R. Duration of infection-derived immunity to cholera. J Infect Dis. 1981 Jun;143(6):818–820. doi: 10.1093/infdis/143.6.818. [DOI] [PubMed] [Google Scholar]
  204. Levine M. M., Black R. E., Clements M. L., Cisneros L., Saah A., Nalin D. R., Gill D. M., Craig J. P., Young C. R., Ristaino P. The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil. J Infect Dis. 1982 Mar;145(3):296–299. doi: 10.1093/infdis/145.3.296. [DOI] [PubMed] [Google Scholar]
  205. Levine M. M., Black R. E., Clements M. L., Young C. R., Lanata C., Sears S., Honda T., Finkelstein R. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Dev Biol Stand. 1983;53:59–65. [PubMed] [Google Scholar]
  206. Levine M. M., Caplan E. S., Waterman D., Cash R. A., Hornick R. B., Snyder M. J. Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun. 1977 Jul;17(1):78–82. doi: 10.1128/iai.17.1.78-82.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Levine M. M., DuPont H. L., Formal S. B., Hornick R. B., Takeuchi A., Gangarosa E. J., Snyder M. J., Libonati J. P. Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery. J Infect Dis. 1973 Mar;127(3):261–270. doi: 10.1093/infdis/127.3.261. [DOI] [PubMed] [Google Scholar]
  208. Levine M. M., DuPont H. L., Hornick R. B., Snyder M. J., Woodward W., Gilman R. H., Libonati J. P. Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization. J Infect Dis. 1976 Apr;133(4):424–429. doi: 10.1093/infdis/133.4.424. [DOI] [PubMed] [Google Scholar]
  209. Levine M. M., Dupont H. L., Gangarosa E. J., Hornick R. B., Snyder M. J., Libonati J. P., Glaser K., Formal S. B. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines. Am J Epidemiol. 1972 Jul;96(1):40–49. doi: 10.1093/oxfordjournals.aje.a121431. [DOI] [PubMed] [Google Scholar]
  210. Levine M. M., Edelman R. Acute diarrheal infections in infants. I. Epidemiology, Treatment, and prospects for immunoprophylaxis. Hosp Pract. 1979 Dec;14(12):89–100. doi: 10.1080/21548331.1979.11707662. [DOI] [PubMed] [Google Scholar]
  211. Levine M. M., Gangarosa E. J., Barrow W. B., Weiss C. F. Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease. Am J Epidemiol. 1976 Jul;104(1):88–92. doi: 10.1093/oxfordjournals.aje.a112277. [DOI] [PubMed] [Google Scholar]
  212. Levine M. M., Gangarosa E. J., Werner M., Morris G. K. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines. J Pediatr. 1974 Jun;84(6):803–806. doi: 10.1016/s0022-3476(74)80751-1. [DOI] [PubMed] [Google Scholar]
  213. Levine M. M., Nalin D. R., Craig J. P., Hoover D., Bergquist E. J., Waterman D., Holley H. P., Hornick R. B., Pierce N. P., Libonati J. P. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans R Soc Trop Med Hyg. 1979;73(1):3–9. doi: 10.1016/0035-9203(79)90119-6. [DOI] [PubMed] [Google Scholar]
  214. Levine M. M., Nalin D. R., Hoover D. L., Bergquist E. J., Hornick R. B., Young C. R. Immunity to enterotoxigenic Escherichia coli. Infect Immun. 1979 Mar;23(3):729–736. doi: 10.1128/iai.23.3.729-736.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Levine M. M., Rennels M. B., Daya V., Hughes T. P. Hemagglutination and colonization factors in enterotoxigenic and enteropathogenic Escherichia coli that cause diarrhea. J Infect Dis. 1980 Jun;141(6):733–737. doi: 10.1093/infdis/141.6.733. [DOI] [PubMed] [Google Scholar]
  216. Levine M. M., Ristaino P., Sack R. B., Kaper J. B., Orskov F., Orskov I. Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type. Infect Immun. 1983 Feb;39(2):889–897. doi: 10.1128/iai.39.2.889-897.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Levine M. M. Travellers' diarrhoea: prospects for successful immunoprophylaxis. Scand J Gastroenterol Suppl. 1983;84:121–134. [PubMed] [Google Scholar]
  218. Levine M. M., Woodward W. E., Formal S. B., Gemski P., Jr, DuPont H. L., Hornick R. B., Snyder M. J. Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri. J Infect Dis. 1977 Oct;136(4):577–582. doi: 10.1093/infdis/136.4.577. [DOI] [PubMed] [Google Scholar]
  219. Levine M. M., Young C. R., Hughes T. P., O'Donnell S., Black R. E., Clements M. L., Robins-Browne R., Lim Y. L. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am J Epidemiol. 1981 Sep;114(3):348–354. doi: 10.1093/oxfordjournals.aje.a113201. [DOI] [PubMed] [Google Scholar]
  220. Levine R. J., Nalin D. R. Cholera is primarily waterborne in Bangladesh. Lancet. 1976 Dec 11;2(7998):1305–1305. doi: 10.1016/s0140-6736(76)92072-9. [DOI] [PubMed] [Google Scholar]
  221. Linde K., Koch H. Untersuchungen zur oralen Immunisierung gegen Coli-Enteritis mit Streptomycin-dependenten Coli-Keimen. 3. Vergleich der Wirksankeit von Impfstoffen aus abgetöteten und lebenden Streptomycin-dependenten EC-O111 B4-Bakterien im aktiven Mäuse-schutzversuch sowie auf die Hemmung der Ansiedlung des homologen Streptomycin-resistenten Stammes bei "darmsteilen" Mäusen. Zentralbl Bakteriol Orig. 1969;211(4):476–485. [PubMed] [Google Scholar]
  222. Loeb M. R., Smith D. H. Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect Immun. 1980 Dec;30(3):709–717. doi: 10.1128/iai.30.3.709-717.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  223. Lumish R. M., Ryder R. W., Anderson D. C., Wells J. G., Puhr N. D. Heat-labile enterotoxigenic Escherichia coli induced diarrhea aboard a Miami-based cruise ship. Am J Epidemiol. 1980 Apr;111(4):432–436. doi: 10.1093/oxfordjournals.aje.a112918. [DOI] [PubMed] [Google Scholar]
  224. Mackaness G. B., Blanden R. V., Collins F. M. Host-parasite relations in mouse typhoid. J Exp Med. 1966 Oct 1;124(4):573–583. doi: 10.1084/jem.124.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Majumdar A. S., Dutta P., Dutta D., Ghose A. C. Antibacterial and antitoxin responses in the serum and milk of cholera patients. Infect Immun. 1981 Apr;32(1):1–8. doi: 10.1128/iai.32.1.1-8.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Majumdar A. S., Ghose A. C. Evaluation of the biological properties of different classes of human antibodies in relation to cholera. Infect Immun. 1981 Apr;32(1):9–14. doi: 10.1128/iai.32.1.9-14.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Mallory F. B. A HISTOLOGICAL STUDY OF TYPHOID FEVER. J Exp Med. 1898 Nov 1;3(6):611–638. [PMC free article] [PubMed] [Google Scholar]
  228. McConnell M. M., Smith H. R., Willshaw G. A., Field A. M., Rowe B. Plasmids coding for colonization factor antigen I and heat-stable enterotoxin production isolated from enterotoxigenic Escherichia coli: comparison of their properties. Infect Immun. 1981 May;32(2):927–936. doi: 10.1128/iai.32.2.927-936.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. McIntyre R. C., Tira T., Flood T., Blake P. A. Modes of transmission of cholera in a newly infected population on an atoll: implications for control measures. Lancet. 1979 Feb 10;1(8111):311–314. doi: 10.1016/s0140-6736(79)90719-0. [DOI] [PubMed] [Google Scholar]
  230. McIver J., Grady G. F., Formal S. B. Immunization with Shigella dysenteriae type 1: evaluation of antitoxic immunity in prevention of experimental disease in rhesus monkeys (Macaca mulatta). J Infect Dis. 1977 Sep;136(3):416–421. doi: 10.1093/infdis/136.3.416. [DOI] [PubMed] [Google Scholar]
  231. Meitert T., Istrati G., Sulea I. T., Baron E., Andronescu C., Gogulescu L., Templea C., Ianopol L., Galan L., Fleşeriu M. Prophylaxie de la dysenterie bacillaire par le vaccin vivant antidysentérique dans une collectivité d'enfants neuropsychiques. Arch Roum Pathol Exp Microbiol. 1973 Mar;32(1):35–44. [PubMed] [Google Scholar]
  232. Mekalanos J. J., Moseley S. L., Murphy J. R., Falkow S. Isolation of enterotoxin structural gene deletion mutations in Vibrio cholerae induced by two mutagenic vibriophages. Proc Natl Acad Sci U S A. 1982 Jan;79(1):151–155. doi: 10.1073/pnas.79.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Mel D. M., Arsic B. L., Radovanovic M. L., Litvinjenko S. A. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose. Acta Microbiol Acad Sci Hung. 1974;21(1-2):109–114. [PubMed] [Google Scholar]
  234. Mel D. M., Arsić B. L., Nikolić B. D., Radovanić M. L. Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Bull World Health Organ. 1968;39(3):375–380. [PMC free article] [PubMed] [Google Scholar]
  235. Mel D. M., Terzin A. L., Vuksić L. Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial. Bull World Health Organ. 1965;32(5):647–655. [PMC free article] [PubMed] [Google Scholar]
  236. Mel D., Gangarosa E. J., Radovanovic M. L., Arsic B. L., Litvinjenko S. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull World Health Organ. 1971;45(4):457–464. [PMC free article] [PubMed] [Google Scholar]
  237. Merson M. H., Black R. E., Sack D. A., Svennerholm A. M., Holmgren J. Maternal cholera immunisation and scecretory IgA in breast milk. Lancet. 1980 Apr 26;1(8174):931–932. doi: 10.1016/s0140-6736(80)90860-0. [DOI] [PubMed] [Google Scholar]
  238. Merson M. H., Martin W. T., Craig J. P., Morris G. K., Blake P. A., Craun G. F., Feeley J. C., Camacho J. C., Gangarosa E. J. Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol. 1977 Apr;105(4):349–361. doi: 10.1093/oxfordjournals.aje.a112393. [DOI] [PubMed] [Google Scholar]
  239. Merson M. H., Morris G. K., Sack D. A., Wells J. G., Feeley J. C., Sack R. B., Creech W. B., Kapikian A. Z., Gangarosa E. J. Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med. 1976 Jun 10;294(24):1299–1305. doi: 10.1056/NEJM197606102942401. [DOI] [PubMed] [Google Scholar]
  240. Merson M. H., Orskov F., Orskov I., Sack R. B., Huq I., Koster F. T. Relationship between enterotoxin production and serotype in enterotoxigenic Escherichia coli. Infect Immun. 1979 Feb;23(2):325–329. doi: 10.1128/iai.23.2.325-329.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  241. Merson M. H., Rowe B., Black R. E., Huq I., Gross R. J., Eusof A. Use of antisera for identification of enterotoxigenic Escherichia coli. Lancet. 1980 Aug 2;2(8188):222–224. doi: 10.1016/s0140-6736(80)90118-x. [DOI] [PubMed] [Google Scholar]
  242. Merson M. H., Sack R. B., Kibriya A. K., Al-Mahmood A., Adamed Q. S., Huq I. Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea. J Clin Microbiol. 1979 Apr;9(4):493–497. doi: 10.1128/jcm.9.4.493-497.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  243. Mochmann H., Ocklitz H. W., Weh L., Heinrich H. Oral immunization with an extract of Escherichia coli enteritidis. Acta Microbiol Acad Sci Hung. 1974;21(1-2):193–196. [PubMed] [Google Scholar]
  244. Moon H. W., Baetz A. L., Giannella R. A. Immunization of swine with heat-stable Escherichia coli enterotoxin coupled to a carrier protein does not protect suckling pigs against an Escherichia coli strain that produces heat-stable enterotoxin. Infect Immun. 1983 Feb;39(2):990–992. doi: 10.1128/iai.39.2.990-992.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Moon H. W., Nagy B., Isaacson R. E., Orskov I. Occurrence of K99 antigen on Escherichia coli isolated from pigs and colonization of pig ileum by K99+ enterotoxigenic E. coli from calves and pigs. Infect Immun. 1977 Feb;15(2):614–620. doi: 10.1128/iai.15.2.614-620.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  246. Moon H. W., Whipp S. C., Argenzio R. A., Levine M. M., Giannella R. A. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect Immun. 1983 Sep;41(3):1340–1351. doi: 10.1128/iai.41.3.1340-1351.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Morgan R. L., Isaacson R. E., Moon H. W., Brinton C. C., To C. C. Immunization of suckling pigs against enterotoxigenic Escherichia coli-induced diarrheal disease by vaccinating dams with purified 987 or K99 pili: protection correlates with pilus homology of vaccine and challenge. Infect Immun. 1978 Dec;22(3):771–777. doi: 10.1128/iai.22.3.771-777.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  248. Moseley S. L., Echeverria P., Seriwatana J., Tirapat C., Chaicumpa W., Sakuldaipeara T., Falkow S. Identification of enterotoxigenic Escherichia coli by colony hybridization using three enterotoxin gene probes. J Infect Dis. 1982 Jun;145(6):863–869. doi: 10.1093/infdis/145.6.863. [DOI] [PubMed] [Google Scholar]
  249. Moseley S. L., Falkow S. Nucleotide sequence homology between the heat-labile enterotoxin gene of Escherichia coli and Vibrio cholerae deoxyribonucleic acid. J Bacteriol. 1980 Oct;144(1):444–446. doi: 10.1128/jb.144.1.444-446.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Moseley S. L., Hardy J. W., Hug M. I., Echeverria P., Falkow S. Isolation and nucleotide sequence determination of a gene encoding a heat-stable enterotoxin of Escherichia coli. Infect Immun. 1983 Mar;39(3):1167–1174. doi: 10.1128/iai.39.3.1167-1174.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  251. Mosley W. H., Aziz K. M., Rahman A. S., Chowdhury A. K., Ahmed A. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation. Bull World Health Organ. 1973;49(4):381–387. [PMC free article] [PubMed] [Google Scholar]
  252. Mosley W. H., Benenson A. S., Barui R. A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera. Bull World Health Organ. 1968;38(3):327–334. [PMC free article] [PubMed] [Google Scholar]
  253. NETER E. Enteritis due to enteropathogenic Escherichia coli; present-day status and unsolved problems. J Pediatr. 1959 Aug;55(2):223–239. doi: 10.1016/s0022-3476(59)80091-3. [DOI] [PubMed] [Google Scholar]
  254. NETER E., SHUMWAY C. N. E. coli serotype D433: occurrence in intestinal and respiratory tracts, cultural characteristics, pathogenicity, sensitivity to antibiotics. Proc Soc Exp Biol Med. 1950 Nov;75(2):504–507. doi: 10.3181/00379727-75-18246. [DOI] [PubMed] [Google Scholar]
  255. Nagy B., Moon H. W., Isaacson R. E., To C. C., Brinton C. C. Immunization of suckling pigs against enteric enterotoxigenic Escherichia coli infection by vaccinating dams with purified pili. Infect Immun. 1978 Jul;21(1):269–274. doi: 10.1128/iai.21.1.269-274.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Nalin D. R., Levine R. J., Levine M. M., Hoover D., Bergquist E., McLaughlin J., Libonati J., Alam J., Hornick R. B. Cholera, non-vibrio cholera, and stomach acid. Lancet. 1978 Oct 21;2(8095):856–859. doi: 10.1016/s0140-6736(78)91568-4. [DOI] [PubMed] [Google Scholar]
  257. Naylor G. R. Incubation period and other features of food-borne and water-borne outbreaks of typhoid fever in relation to pathogenesis and genetics of resistance. Lancet. 1983 Apr 16;1(8329):864–866. doi: 10.1016/s0140-6736(83)91395-8. [DOI] [PubMed] [Google Scholar]
  258. Nelson E. T., Clements J. D., Finkelstein R. A. Vibrio cholerae adherence and colonization in experimental cholera: electron microscopic studies. Infect Immun. 1976 Aug;14(2):527–547. doi: 10.1128/iai.14.2.527-547.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Northrup R. S., Chisari F. V. Response of monkeys to immunization with cholera toxoid, toxin, and vaccine: reversion of cholera toxoid. J Infect Dis. 1972 May;125(5):471–479. doi: 10.1093/infdis/125.5.471. [DOI] [PubMed] [Google Scholar]
  260. O'Brien A. D., LaVeck G. D., Griffin D. E., Thompson M. R. Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun. 1980 Oct;30(1):170–179. doi: 10.1128/iai.30.1.170-179.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  261. O'Brien A. D., LaVeck G. D., Thompson M. R., Formal S. B. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis. 1982 Dec;146(6):763–769. doi: 10.1093/infdis/146.6.763. [DOI] [PubMed] [Google Scholar]
  262. Ogawa H., Nakamura A., Nakaya R. Cinemicrographic study of tissue cell cultures infected with Shigella flexneri. Jpn J Med Sci Biol. 1968 Aug;21(4):259–273. doi: 10.7883/yoken1952.21.259. [DOI] [PubMed] [Google Scholar]
  263. Okamura N., Nagai T., Nakaya R., Kondo S., Murakami M., Hisatsune K. HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs. Infect Immun. 1983 Feb;39(2):505–513. doi: 10.1128/iai.39.2.505-513.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  264. Orskov F., Orskov I., Evans D. J., Jr, Sack R. B., Sack D. A., Wadström T. Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol. 1976 Jun 1;162(2):73–80. doi: 10.1007/BF02121318. [DOI] [PubMed] [Google Scholar]
  265. Orskov I., Orskov F. Episome-carried surface antigen K88 of Escherichia coli. I. Transmission of the determinant of the K88 antigen and influence on the transfer of chromosomal markers. J Bacteriol. 1966 Jan;91(1):69–75. doi: 10.1128/jb.91.1.69-75.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  266. Orskov I., Orskov F., Smith H. W., Sojka W. J. The establishment of K99, a thermolabile, transmissible escherichia coli K antigen, previously called "Kco", possessed by calf and lamb enteropathogenic strains. Acta Pathol Microbiol Scand B. 1975 Feb;83(1):31–36. doi: 10.1111/j.1699-0463.1975.tb00066.x. [DOI] [PubMed] [Google Scholar]
  267. Orskov I., Orskov F. Special O:K:H serotypes among enterotoxigenic E. coli strains from diarrhea in adults and children. Occurrence of the CF (colonization factor) antigen and of hemagglutinating abilities. Med Microbiol Immunol. 1977 Jul 18;163(2):99–110. doi: 10.1007/BF02121825. [DOI] [PubMed] [Google Scholar]
  268. Osada Y., Ogawa H. A possible role of glycolipids in epithelial cell penetration by virulent Shigella flexneri 2a. Microbiol Immunol. 1977;21(7):405–410. doi: 10.1111/j.1348-0421.1977.tb00304.x. [DOI] [PubMed] [Google Scholar]
  269. Osada Y., Ogawa H. Phagocytosis stimulation by an extracellular product of virulent Shigella flexneri 2a. Microbiol Immunol. 1977;21(1):49–55. doi: 10.1111/j.1348-0421.1977.tb02807.x. [DOI] [PubMed] [Google Scholar]
  270. Osada Y., Une T., Ikeuchi T., Ogawa H. Divalent cation stimulation of the cell infectivity of Shigella flexneri 2a. Jpn J Microbiol. 1975 Apr;19(2):163–166. doi: 10.1111/j.1348-0421.1975.tb00863.x. [DOI] [PubMed] [Google Scholar]
  271. Osada Y., Une T., Ikeuchi T., Ogawa H. Effect of calcium on the cell infectivity of virulent Shigella flexneri 2a. Jpn J Microbiol. 1974 Jul;18(4):321–326. doi: 10.1111/j.1348-0421.1974.tb00816.x. [DOI] [PubMed] [Google Scholar]
  272. Peterson J. W., Hejtmancik K. E., Markel D. E., Craig J. P., Kurosky A. Antigenic specificity of neutralizing antibody to cholera toxin. Infect Immun. 1979 Jun;24(3):774–779. doi: 10.1128/iai.24.3.774-779.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  273. Peterson J. W. Protection against experimental cholera by oral or parenteral immunization. Infect Immun. 1979 Nov;26(2):594–598. doi: 10.1128/iai.26.2.594-598.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  274. Pierce N. F., Cray W. C., Jr, Sacci J. B., Jr, Craig J. P., Germanier R., Fürer E. Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera. Infect Immun. 1983 Jun;40(3):1112–1118. doi: 10.1128/iai.40.3.1112-1118.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Pierce N. F., Cray W. C., Jr, Sacci J. B., Jr Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect Immun. 1982 Aug;37(2):687–694. doi: 10.1128/iai.37.2.687-694.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  276. Pierce N. F., Cray W. C., Jr, Sircar B. K. Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera. Infect Immun. 1978 Jul;21(1):185–193. doi: 10.1128/iai.21.1.185-193.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  277. Pierce N. F., Sack R. B., Sircar B. K. Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis. 1977 Jun;135(6):888–896. doi: 10.1093/infdis/135.6.888. [DOI] [PubMed] [Google Scholar]
  278. Polotsky Y. E., Dragunskaya E. M., Seliverstova V. G., Avdeeva T. A., Chakhutinskaya M. G., Kétyi I., Vertényl A., Ralovich B., Emödy L., Málovics I. Pathogenic effect of enterotoxigenic Escherichia coli and Escherichia coli causing infantile diarrhoea. Acta Microbiol Acad Sci Hung. 1977;24(3):221–236. [PubMed] [Google Scholar]
  279. Rao M. C., Orellana S. A., Field M., Robertson D. C., Giannella R. A. Comparison of the biological actions of three purified heat-stable enterotoxins: effects on ion transport and guanylate cyclase activity in rabbit ileum in vitro. Infect Immun. 1981 Jul;33(1):165–170. doi: 10.1128/iai.33.1.165-170.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. Rappaport R. S., Pierzchala W. A., Bonde G., McCann T., Rubin B. A. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen. Infect Immun. 1976 Sep;14(3):687–693. doi: 10.1128/iai.14.3.687-693.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  281. Rauss K., Kétyi I., Matusovits E., Szendrel L., Vertényi A., Várbiró B. Specific oral prevention of infantile enteritis. 3. Experiments with corpuscular vaccine. Acta Microbiol Acad Sci Hung. 1972;19(1):19–28. [PubMed] [Google Scholar]
  282. Rauss K., Kétyi I., Szendrei L., Vertényi A. Immunization of infants against Escherichia coli enteritis. Acta Microbiol Acad Sci Hung. 1974;21(1-2):181–185. [PubMed] [Google Scholar]
  283. Reis M. H., Heloiza M., Affonso T., Trabulsi L. R., Mazaitis A. J., Maas R., Maas W. K. Transfer of a CFA/I-ST plasmid promoted by a conjugative plasmid in a strain of Escherichia coli of serotype O128ac:H12. Infect Immun. 1980 Jul;29(1):140–143. doi: 10.1128/iai.29.1.140-143.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  284. Reis M. H., Matos D. P., de Castro A. F., Toledo M. R., Trabulsi L. R. Relationship among enterotoxigenic phenotypes, serotypes, and sources of strains in enterotoxigenic Escherichia coli. Infect Immun. 1980 Apr;28(1):24–27. doi: 10.1128/iai.28.1.24-27.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  285. Reitman M. Infectivity and antigenicity of streptomycin-dependent Salmonella typhosa. J Infect Dis. 1967 Feb;117(1):101–107. doi: 10.1093/infdis/117.1.101. [DOI] [PubMed] [Google Scholar]
  286. Resnick I. G., Ford C. W., Shackleford G. M., Berry L. J. Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine. Infect Immun. 1980 Nov;30(2):375–380. doi: 10.1128/iai.30.2.375-380.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  287. Robertsson J. A., Fossum C., Svenson S. B., Lindberg A. A. Salmonella typhimurium infection in calves: specific immune reactivity against O-antigenic polysaccharide detectable in in vitro assays. Infect Immun. 1982 Aug;37(2):728–736. doi: 10.1128/iai.37.2.728-736.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Robertsson J. A., Lindberg A. A., Hoiseth S., Stocker B. A. Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines. Infect Immun. 1983 Aug;41(2):742–750. doi: 10.1128/iai.41.2.742-750.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  289. Robertsson J. A., Svenson S. B., Lindberg A. A. Salmonella typhimurium infection in calves: delayed specific skin reactions directed against the O-antigenic polysaccharide chain. Infect Immun. 1982 Aug;37(2):737–748. doi: 10.1128/iai.37.2.737-748.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  290. Robins-Browne R. M., Young C. R., Levine M. M., Craig J. P. Microtiter enzyme-linked immunosorbent assay for immunoglobulin g cholera antitoxin in humans: sensitivity and specificity. Infect Immun. 1980 Feb;27(2):497–500. doi: 10.1128/iai.27.2.497-500.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Rothbaum R., McAdams A. J., Giannella R., Partin J. C. A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants. Gastroenterology. 1982 Aug;83(2):441–454. [PubMed] [Google Scholar]
  292. Rutter J. M., Jones G. W. Protection against enteric disease caused by Escherichia coli--a model for vaccination with a virulence determinant? Nature. 1973 Apr 20;242(5399):531–532. doi: 10.1038/242531a0. [DOI] [PubMed] [Google Scholar]
  293. Sack D. A., Kaminsky D. C., Sack R. B., Itotia J. N., Arthur R. R., Kapikian A. Z., Orskov F., Orskov I. Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med. 1978 Apr 6;298(14):758–763. doi: 10.1056/NEJM197804062981402. [DOI] [PubMed] [Google Scholar]
  294. Sack D. A., McLaughlin J. C., Sack R. B., Orskov F., Orskov I. Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis. 1977 Feb;135(2):275–280. doi: 10.1093/infdis/135.2.275. [DOI] [PubMed] [Google Scholar]
  295. Sack R. B., Hirschhorn N., Brownlee I., Cash R. A., Woodward W. E., Sack D. A. Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med. 1975 May 15;292(20):1041–1045. doi: 10.1056/NEJM197505152922001. [DOI] [PubMed] [Google Scholar]
  296. Sack R. B. Letter: Serotyping of E. coli. Lancet. 1976 May 22;1(7969):1132–1132. [PubMed] [Google Scholar]
  297. Salmaso S., Greco D., Bonfiglio B., Castellani-Pastoris M., De Felip G., Bracciotti A., Sitzia G., Congiu A., Piu G., Angioni G. Recurrence of Pelecypod-associated cholera in Sardinia. Lancet. 1980 Nov 22;2(8204):1124–1127. doi: 10.1016/s0140-6736(80)92553-2. [DOI] [PubMed] [Google Scholar]
  298. Samadi A. R., Huq M. I., Shahid N., Khan M. U., Eusof A., Rahman A. S., Yunus M., Faruque A. S. Classical Vibrio cholerae biotype displaces EL tor in Bangladesh. Lancet. 1983 Apr 9;1(8328):805–807. doi: 10.1016/s0140-6736(83)91860-3. [DOI] [PubMed] [Google Scholar]
  299. Sansonetti P. J., Hale T. L., Dammin G. J., Kapfer C., Collins H. H., Jr, Formal S. B. Alterations in the pathogenicity of Escherichia coli K-12 after transfer of plasmid and chromosomal genes from Shigella flexneri. Infect Immun. 1983 Mar;39(3):1392–1402. doi: 10.1128/iai.39.3.1392-1402.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  300. Sansonetti P. J., Kopecko D. J., Formal S. B. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect Immun. 1982 Mar;35(3):852–860. doi: 10.1128/iai.35.3.852-860.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  301. Sansonetti P., David M., Toucas M. Corrélation entre la perte d'ADN plasmidique et le passage de la phase I virulente à la phase II avirulente chez Shigella sonnei. C R Seances Acad Sci D. 1980 Mar 31;290(13):879–882. [PubMed] [Google Scholar]
  302. Saroso J. S., Bahrawi W., Witjaksono H., Budiarso R. L., Brotowasisto, Bencić Z., Dewitt W. E., Gomez C. Z. A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75. Bull World Health Organ. 1978;56(4):619–627. [PMC free article] [PubMed] [Google Scholar]
  303. Satterwhite T. K., Evans D. G., DuPont H. L., Evans D. J., Jr Role of Escherichia coli colonisation factor antigen in acute diarrhoea. Lancet. 1978 Jul 22;2(8082):181–184. doi: 10.1016/s0140-6736(78)91921-9. [DOI] [PubMed] [Google Scholar]
  304. Schneider D. R., Parker C. D. Isolation and characterization of protease-deficient mutants of vibrio cholerae. J Infect Dis. 1978 Aug;138(2):143–151. doi: 10.1093/infdis/138.2.143. [DOI] [PubMed] [Google Scholar]
  305. Schrank G. D., Verwey W. F. Distribution of cholera organisms in experimental Vibrio cholerae infections: proposed mechanisms of pathogenesis and antibacterial immunity. Infect Immun. 1976 Jan;13(1):195–203. doi: 10.1128/iai.13.1.195-203.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  306. Shore E. G., Dean A. G., Holik K. J., Davis B. R. Enterotoxin-producing Escherichia coli and diarrheal disease in adult travelers: a prospective study. J Infect Dis. 1974 May;129(5):577–582. doi: 10.1093/infdis/129.5.577. [DOI] [PubMed] [Google Scholar]
  307. Skerman F. J., Formal S. B., Falkow S. Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans. Infect Immun. 1972 Apr;5(4):622–624. doi: 10.1128/iai.5.4.622-624.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. Skirrow M. B. Campylobacter enteritis: a "new" disease. Br Med J. 1977 Jul 2;2(6078):9–11. doi: 10.1136/bmj.2.6078.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  309. Smith H. W., Linggood M. A. Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. J Med Microbiol. 1971 Nov;4(4):467–485. doi: 10.1099/00222615-4-4-467. [DOI] [PubMed] [Google Scholar]
  310. Smith H. W., Linggood M. A. The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli. J Med Microbiol. 1971 Aug;4(3):301–305. doi: 10.1099/00222615-4-3-301. [DOI] [PubMed] [Google Scholar]
  311. Smyth C. J. Two mannose-resistant haemagglutinins on enterotoxigenic Escherichia coli of serotype O6:K15:H16 or H-isolated from travellers' and infantile diarrhoea. J Gen Microbiol. 1982 Sep;128(9):2081–2096. doi: 10.1099/00221287-128-9-2081. [DOI] [PubMed] [Google Scholar]
  312. So M., Heffron F., McCarthy B. J. The E. coli gene encoding heat stable toxin is a bacterial transposon flanked by inverted repeats of IS1. Nature. 1979 Feb 8;277(5696):453–456. doi: 10.1038/277453a0. [DOI] [PubMed] [Google Scholar]
  313. So M., McCarthy B. J. Nucleotide sequence of the bacterial transposon Tn1681 encoding a heat-stable (ST) toxin and its identification in enterotoxigenic Escherichia coli strains. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4011–4015. doi: 10.1073/pnas.77.7.4011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  314. Spicer E. K., Noble J. A. Escherichia coli heat-labile enterotoxin. Nucleotide sequence of the A subunit gene. J Biol Chem. 1982 May 25;257(10):5716–5721. [PubMed] [Google Scholar]
  315. Spira W. M., Khan M. U., Saeed Y. A., Sattar M. A. Microbiological surveillance of intra-neighbourhood E1 Tor cholera transmission in rural Bangladesh. Bull World Health Organ. 1980;58(5):731–740. [PMC free article] [PubMed] [Google Scholar]
  316. Sprinz H., Gangarosa E. J., Williams M., Hornick R. B., Woodward T. E. Histopathology of the upper small intestines in typhoid fever. Biopsy study of experimental disease in man. Am J Dig Dis. 1966 Aug;11(8):615–624. doi: 10.1007/BF02233509. [DOI] [PubMed] [Google Scholar]
  317. Sprinz H. Pathogenesis of intestinal infections. Arch Pathol. 1969 Jun;87(6):556–562. [PubMed] [Google Scholar]
  318. Stirm S., Orskov F., Orskov I., Birch-Andersen A. Episome-carried surface antigen K88 of Escherichia coli. 3. Morphology. J Bacteriol. 1967 Feb;93(2):740–748. doi: 10.1128/jb.93.2.740-748.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  319. Stocker B. A., Hoiseth S. K., Smith B. P. Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves. Dev Biol Stand. 1983;53:47–54. [PubMed] [Google Scholar]
  320. Svennerholm A. M., Ahrén C. Immune protection against enterotoxinogenic E. coli: search for synergy between antibodies to enterotoxin and somatic antigens. Acta Pathol Microbiol Immunol Scand C. 1982 Feb;90(1):1–6. doi: 10.1111/j.1699-0463.1982.tb01409.x. [DOI] [PubMed] [Google Scholar]
  321. Svennerholm A. M., Hanson L. A., Holmgren J., Lindblad B. S., Nilsson B., Quereshi F. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect Immun. 1980 Nov;30(2):427–430. doi: 10.1128/iai.30.2.427-430.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Svennerholm A. M., Holmgren J., Hanson L. A., Lindblad B. S., Quereshi F., Rahimtoola R. J. Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination. Scand J Immunol. 1977;6(12):1345–1349. doi: 10.1111/j.1365-3083.1977.tb00376.x. [DOI] [PubMed] [Google Scholar]
  323. Svennerholm A. M., Holmgren J. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid. Infect Immun. 1976 Mar;13(3):735–740. doi: 10.1128/iai.13.3.735-740.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  324. Svennerholm A. M., Sack D. A., Holmgren J., Bardhan P. K. Intestinal antibody responses after immunisation with cholera B subunit. Lancet. 1982 Feb 6;1(8267):305–308. doi: 10.1016/s0140-6736(82)91568-9. [DOI] [PubMed] [Google Scholar]
  325. Svenson S. B., Lindberg A. A. Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit protective antibodies in rabbits and mice. Infect Immun. 1981 May;32(2):490–496. doi: 10.1128/iai.32.2.490-496.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  326. Svenson S. B., Nurminen M., Lindberg A. A. Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun. 1979 Sep;25(3):863–872. doi: 10.1128/iai.25.3.863-872.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  327. Swanson J. Surface-exposed protein antigens of the gonococcal outer membrane. Infect Immun. 1981 Dec;34(3):804–816. doi: 10.1128/iai.34.3.804-816.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  328. Swarbrick E. T., Stokes C. R., Soothill J. F. Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance. Gut. 1979 Feb;20(2):121–125. doi: 10.1136/gut.20.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  329. Söderlind O., Möllby R. Enterotoxins, O-groups, and K88 antigen in Escherichia coli from neonatal piglets with and without diarrhea. Infect Immun. 1979 Jun;24(3):611–616. doi: 10.1128/iai.24.3.611-616.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  330. Takeda Y., Honda T., Taga S., Miwatani T. In vitro formation of hybrid toxins between subunits of Escherichia coli heat-labile enterotoxin and those of cholera enterotoxin. Infect Immun. 1981 Nov;34(2):341–346. doi: 10.1128/iai.34.2.341-346.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  331. Takeuchi A. Electron microscope studies of experimental Salmonella infection. I. Penetration into the intestinal epithelium by Salmonella typhimurium. Am J Pathol. 1967 Jan;50(1):109–136. [PMC free article] [PubMed] [Google Scholar]
  332. Takeuchi A., Sprinz H. Electron-Microscope Studies of Experimental Salmonella Infection in the Preconditioned Guinea Pig: II. Response of the Intestinal Mucosa to the Invasion by Salmonella typhimurium. Am J Pathol. 1967 Jul;51(1):137–161. [PMC free article] [PubMed] [Google Scholar]
  333. Takeuchi A., Sprinz H., LaBrec E. H., Formal S. B. Experimental bacillary dysentery. An electron microscopic study of the response of the intestinal mucosa to bacterial invasion. Am J Pathol. 1965 Dec;47(6):1011–1044. [PMC free article] [PubMed] [Google Scholar]
  334. Thomas D. D., Knoop F. C. Effect of heat-stable enterotoxin of Escherichia coli on cultured mammalian cells. J Infect Dis. 1983 Mar;147(3):450–459. doi: 10.1093/infdis/147.3.450. [DOI] [PubMed] [Google Scholar]
  335. Thomas L. V., Cravioto A., Scotland S. M., Rowe B. New fimbrial antigenic type (E8775) that may represent a colonization factor in enterotoxigenic Escherichia coli in humans. Infect Immun. 1982 Mar;35(3):1119–1124. doi: 10.1128/iai.35.3.1119-1124.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  336. Tomasi T. B., Jr Oral tolerance. Transplantation. 1980 May;29(5):353–356. doi: 10.1097/00007890-198005000-00001. [DOI] [PubMed] [Google Scholar]
  337. Ulshen M. H., Rollo J. L. Pathogenesis of escherichia coli gastroenteritis in man--another mechanism. N Engl J Med. 1980 Jan 10;302(2):99–101. doi: 10.1056/NEJM198001103020207. [DOI] [PubMed] [Google Scholar]
  338. VAN HEYNINGEN W. E., GLADSTONE G. P. The neurotoxin of Shigella shigae. I. Production, purification and properties of the toxin. Br J Exp Pathol. 1953 Apr;34(2):202–216. [PMC free article] [PubMed] [Google Scholar]
  339. VICARI G., OLITZKI A. L., OLITZKI Z. The action of the thermolabile toxin of Shigella dysenteriae on cells cultivated in vitro. Br J Exp Pathol. 1960 Apr;41:179–189. [PMC free article] [PubMed] [Google Scholar]
  340. WENTWORTH F. H., BROCK D. W., STULBERG C. S., PAGE R. H. Clinical, bacteriological, and serological observations of two human volunteers following ingestion of Escherichia coli O127:B8. Proc Soc Exp Biol Med. 1956 Apr;91(4):586–588. doi: 10.3181/00379727-91-22338. [DOI] [PubMed] [Google Scholar]
  341. Wahdan M. H., Serie C., Germanier R., Lackany A., Cerisier Y., Guerin N., Sallam S., Geoffroy P., el Tantawi A. S., Guesry P. A controlled field trial of liver oral typhoid vaccine Ty21a. Bull World Health Organ. 1980;58(3):469–474. [PMC free article] [PubMed] [Google Scholar]
  342. Wahdan M. H., Sérié C., Cerisier Y., Sallam S., Germanier R. A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results. J Infect Dis. 1982 Mar;145(3):292–295. doi: 10.1093/infdis/145.3.292. [DOI] [PubMed] [Google Scholar]
  343. Wong K. H., Feeley J. C., Northrup R. S., Forlines M. E. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals. Infect Immun. 1974 Feb;9(2):348–353. doi: 10.1128/iai.9.2.348-353.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  344. Woodward W. E., Gilman R. H., Hornick R. B., Libonati J. P., Cash R. A. Efficacy of a live oral cholera vaccine in human volunteers. Dev Biol Stand. 1976;33:108–112. [PubMed] [Google Scholar]
  345. Yamamoto T., Yokota T., Kaji A. Molecular organization of heat-labile enterotoxin genes originating in Escherichia coli of human origin and construction of heat-labile toxoid-producing strains. J Bacteriol. 1981 Dec;148(3):983–987. doi: 10.1128/jb.148.3.983-987.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  346. Young C. R., Levine M. M., Craig J. P., Robins-Browne R. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique. Infect Immun. 1980 Feb;27(2):492–496. doi: 10.1128/iai.27.2.492-496.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  347. van Heyningen S. Cholera toxin. Biol Rev Camb Philos Soc. 1977 Nov;52(4):509–509. doi: 10.1111/j.1469-185x.1977.tb00858.x. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES